+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fibroid"

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine Leiomyoma (Uterine Fibroids) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Uterine leiomyosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine leiomyosarcoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
From
From
Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029 - Product Thumbnail Image

Middle East & Africa IVF (in-vitro fertilization) Market Outlook, 2029

  • Report
  • May 2024
  • 68 Pages
  • Africa, Middle East
From
Therapeutics for Women's Health: Technologies and Global Markets - Product Thumbnail Image

Therapeutics for Women's Health: Technologies and Global Markets

  • Report
  • January 2022
  • 258 Pages
  • Global
From
From
From
From
Gynecology Medical Lasers Global Market Report 2024 - Product Thumbnail Image

Gynecology Medical Lasers Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
Loading Indicator

The Fibroid market is a subset of the Women's Health market, focusing on the diagnosis and treatment of uterine fibroids. Fibroids are non-cancerous growths that can cause a variety of symptoms, including heavy menstrual bleeding, pelvic pain, and frequent urination. Treatment options range from medication to minimally invasive procedures to surgical removal. The Fibroid market is a growing area of Women's Health, with a variety of companies offering products and services to diagnose and treat fibroids. Companies in the market include Hologic, Inc., Boston Scientific Corporation, Cook Medical, Inc., and Olympus Corporation. Show Less Read more